bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.04.647187

Investigating microbiota differences across chronic pancreatitis, influenced by lifestyle and genetic determinants

Abstract

BackgroundChronic pancreatitis (CP) is a multifaceted and irreversible inflammatory condition that impacts both endocrine and exocrine pancreatic functions. Whilst there is evidence of a general intestinal microbial dysbiosis, differences across CP resulting from diverse triggers remains poorly elucidated. MethodsIn this study, we investigated how different CP triggers, namely alcohol-induced CP (AIP) and CFTR-related CP (CFRP), might undermine differences across microbiota structure and predicted function. Faecal samples from 25 CP participants were collected, alongside 9 healthy controls for microbiota analyses. Both full and short (V4) 16S rRNA sequencing was performed, including predicted functionality using PICRUSt2. Clinical metadata was integrated to investigate relationships with microbiota structure and predicted functionality with ordination-based approaches. ResultsMicrobiota diversity patterns between groups varied slightly by sequencing approach, with differences across common core and rarer satellite taxa diversity evident. Importantly, microbiota compositional profiles were shared between approaches, with control samples clustering closer than CP samples. Between groups, significant differences in microbiota composition were apparent, with the AIP group significantly different to both control and CFRP groups across various microbiota partitions (P < 0.05). Notable genera drove the observed dissimilarity, including Bifidobacterium, Faecalibacterium, and Ruminococcus, which were decreased in relative abundance across CP. Predictive functional analyses further demonstrated increased similarity of controls as compared to CP groups. Significant variation across both microbiota structure and predicted function was explained by CP subtype (P < 0.01). When compared back to controls, the relative abundance of various predicted functional pathways from both the core and satellite taxa was significantly different across groups (P < 0.05). ConclusionsOverall, we demonstrate that gut microbiota structure and predicted function differs between not only healthy controls and CP, including across CP subtypes themselves. Various taxa with important physiological roles were implicated across CP. Differences in predicted functionality of the core and satellite taxa were evident, relating to microbial processes that may have downstream consequences at the site of the GI tract. Future studies will employ larger cohorts with the incorporation of additional omics-based approaches. This will better elucidate differences in microbiota structure and functionality across CP, including relationships with pancreatic-based clinical outcomes.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ahmed, A. Y. M., Rajai, A., Fullwood, C., Rivett, D. W., McLaughlin, J., van der Gast, C., Marsh, R.. 2025-04-04. Investigating microbiota differences across chronic pancreatitis, influenced by lifestyle and genetic determinants. https://doi.org/10.1101/2025.04.04.647187

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗